<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01541163</url>
  </required_header>
  <id_info>
    <org_study_id>NT 11046-6/2010</org_study_id>
    <secondary_id>Grant project No.86-17</secondary_id>
    <nct_id>NCT01541163</nct_id>
  </id_info>
  <brief_title>Heart and Ischemic STrOke Relationship studY</brief_title>
  <acronym>HISTORY</acronym>
  <official_title>Assessment of Relationship Between Acute Ischemic Stroke and Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital Olomouc</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, Czech Republic</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Palacky University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Hospital Olomouc</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Although cardio-embolic etiology of ischemic stroke (IS) is largely respected, there is still
      no clear recommendation for routine complex cardiological examination in all IS patients.
      Using complex cardiological examination the investigators expect:

        1. more accurate detection of patients with concomitant heart disease (cardiac rhythm
           disorder, valve disorders, acute coronary syndrome, cardiac thrombus and myxoma, atrial
           and ventricle septum defects)

        2. higher number of etiologically determinated IS, which is crucial for accurate secondary
           prevention.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The investigators expect significant changes of biochemical parameters (NT pro B-type of
      natriuretic peptide, pro-atrial natriuretic peptide, creatinkinase MB, troponin T),
      inflammatory markers (interleukine 6, procalcitonin, high sensitive C-reactive protein), and
      coagulation parameters in patients with CE IS compared to other causes of IS.

      Assessing the glomerular filtration of cystatin C, glycated haemoglobin and serum lipids and
      its correlation with prior medicament use will allow to evaluate the long-term compensation
      of arterial hypertension, diabetes mellitus and dyslipidemia in IS patients.

      In addition to the above mentioned comprehensive cardiological examinations, 1- and 3-week
      ECG-Holter will be performed in subpopulation of patients old up to 50 years and with
      cryptogenic ischemic stroke in the period from 1st May 2013 to 31st December 2015. These
      patients will also fill in a special epidemiologic questionnaire. Anticipated enrollment in
      this substudy of HISTORY study is 40 - 80 patients.

      In selected young cryptogenic stroke patients, a subcutaneous cardiac monitor was implanted
      for the detection of paroxysmal atrial fibrillation in the period from 1st January 2014 to
      31st December 2015.

      From 2016 in young ischemic stroke (IS) patients under 50 years, a standard
      perfusion/ventilation scintigraphy of lungs will be performed to exclude acute pulmonary
      embolization (coincidental) in case of elevated serum D-dimers after admission.

      In all enrolled young IS patients, a BP Holter will be performed after the discharge home to
      exclude possible arterial hypertension, which did not presented during hospitalization.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2010</start_date>
  <completion_date type="Anticipated">November 2018</completion_date>
  <primary_completion_date type="Anticipated">June 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>To assess the serum level profile of cardiac troponin T (cTnT) in acute ischemic stroke (AIS) patients and to evaluate factors associated with increased serum level of cTnT.</measure>
    <time_frame>Within 12 hours after ischemic stroke onset.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Correlation between location and volume of brain infarction.</measure>
    <time_frame>At admission within 12 hours after stroke onset and after 24hours.</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Brain Ischemia</condition>
  <condition>Acute Stroke</condition>
  <condition>Heart Diseases</condition>
  <arm_group>
    <arm_group_label>Acute Ischemic Stroke</arm_group_label>
    <description>Patients with acute ischemic stroke admitted within 12 hours after onset.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Consecutive ischemic stroke patients within 12 hours from stroke onset, who will be
        admitted at Comprehensive Stroke Center, Department of Neurology, University Hospital
        Olomouc from the October 2010 until December 2015.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Ischemic stroke admitted within 12 hours from stroke onset at stroke center

        Exclusion Criteria:
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michal Kral, MD</last_name>
    <role>Study Director</role>
    <affiliation>University Hospital Olomouc</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Michal Kral, MD</last_name>
    <phone>+420 604 171 594</phone>
    <email>michal.kral@fnol.cz</email>
  </overall_contact>
  <location>
    <facility>
      <name>University Hospital Olomouc</name>
      <address>
        <city>Olomouc</city>
        <zip>775 20</zip>
        <country>Czechia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Michal Kral, MD</last_name>
      <phone>+420 604 171 594</phone>
      <email>michal.kral@fnol.cz</email>
    </contact>
    <investigator>
      <last_name>Michal Kral, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Daniel Sanak, MD,PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomas Veverka, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Skoloudik, MD,PhD,prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roman Herzig, MD,PhD,prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andrea Bartkova, MD., PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Martin Hutyra, MD., PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Vindis, MD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Petr Kanovsky, MD,PhD,prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Anna Kuncarova</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Milos Taborsky, MD,PhD,prof.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tomas Skala, MD, PhD.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Czechia</country>
  </location_countries>
  <removed_countries>
    <country>Czech Republic</country>
  </removed_countries>
  <link>
    <url>http://www.fnol.cz/</url>
    <description>University Hospital Olomouc</description>
  </link>
  <link>
    <url>http://www.mzcr.cz/</url>
    <description>Ministry of Health of Czech Republic</description>
  </link>
  <link>
    <url>http://biomed.papers.upol.cz/pdfs/bio/2012/03/16.pdf</url>
    <description>Biomedical Papers - Protocol of a prospective observational trial</description>
  </link>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/23566538</url>
    <description>Kral M et al. Troponin T in Acute Ischemic Stroke. Am J Cardiol. 2013 Jul 1;112(1):117-21. Epub 2013 Apr 6.</description>
  </link>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2012</study_first_submitted>
  <study_first_submitted_qc>February 28, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 29, 2012</study_first_posted>
  <last_update_submitted>October 31, 2017</last_update_submitted>
  <last_update_submitted_qc>October 31, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital Olomouc</investigator_affiliation>
    <investigator_full_name>Michal Kral</investigator_full_name>
    <investigator_title>Study Director</investigator_title>
  </responsible_party>
  <keyword>Ischemia</keyword>
  <keyword>Brain Infarction</keyword>
  <keyword>Acute Stroke</keyword>
  <keyword>Heart Diseases</keyword>
  <keyword>Myocardial Infarction</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Stroke</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

